146 related articles for article (PubMed ID: 28039784)
1. Verteporfin based silica nanoparticle for in vitro selective inhibition of human highly invasive melanoma cell proliferation.
Rizzi M; Tonello S; Estevão BM; Gianotti E; Marchese L; Renò F
J Photochem Photobiol B; 2017 Feb; 167():1-6. PubMed ID: 28039784
[TBL] [Abstract][Full Text] [Related]
2. Verteporfin-loaded mesoporous silica nanoparticles inhibit mouse melanoma proliferation in vitro and in vivo.
Clemente N; Miletto I; Gianotti E; Invernizzi M; Marchese L; Dianzani U; Renò F
J Photochem Photobiol B; 2019 Aug; 197():111533. PubMed ID: 31254952
[TBL] [Abstract][Full Text] [Related]
3. An efficient rose bengal based nanoplatform for photodynamic therapy.
Gianotti E; Martins Estevão B; Cucinotta F; Hioka N; Rizzi M; Renò F; Marchese L
Chemistry; 2014 Aug; 20(35):10921-5. PubMed ID: 25116185
[TBL] [Abstract][Full Text] [Related]
4. Multifunctional mesoporous silica nanoplatform based on silicon nanoparticles for targeted two-photon-excited fluorescence imaging-guided chemo/photodynamic synergetic therapy in vitro.
Li S; Zhang Y; He XW; Li WY; Zhang YK
Talanta; 2020 Mar; 209():120552. PubMed ID: 31892096
[TBL] [Abstract][Full Text] [Related]
5. The promotion of human malignant melanoma growth by mesoporous silica nanoparticles through decreased reactive oxygen species.
Huang X; Zhuang J; Teng X; Li L; Chen D; Yan X; Tang F
Biomaterials; 2010 Aug; 31(24):6142-53. PubMed ID: 20510446
[TBL] [Abstract][Full Text] [Related]
6. Multifunctional ZnPc-loaded mesoporous silica nanoparticles for enhancement of photodynamic therapy efficacy by endolysosomal escape.
Tu J; Wang T; Shi W; Wu G; Tian X; Wang Y; Ge D; Ren L
Biomaterials; 2012 Nov; 33(31):7903-14. PubMed ID: 22840227
[TBL] [Abstract][Full Text] [Related]
7. Co-Delivery of Cisplatin Prodrug and Chlorin e6 by Mesoporous Silica Nanoparticles for Chemo-Photodynamic Combination Therapy to Combat Drug Resistance.
Zhang W; Shen J; Su H; Mu G; Sun JH; Tan CP; Liang XJ; Ji LN; Mao ZW
ACS Appl Mater Interfaces; 2016 Jun; 8(21):13332-40. PubMed ID: 27164222
[TBL] [Abstract][Full Text] [Related]
8. Enhanced Fluorescence Imaging and Photodynamic Cancer Therapy Using Hollow Mesoporous Nanocontainers.
Hong SH; Kim H; Choi Y
Chem Asian J; 2017 Jul; 12(14):1700-1703. PubMed ID: 28463441
[TBL] [Abstract][Full Text] [Related]
9. Verteporfin, photofrin II, and merocyanine 540 as PDT photosensitizers against melanoma cells.
Nowak-Sliwinska P; Karocki A; Elas M; Pawlak A; Stochel G; Urbanska K
Biochem Biophys Res Commun; 2006 Oct; 349(2):549-55. PubMed ID: 16945338
[TBL] [Abstract][Full Text] [Related]
10. Cyclodextrin-gated mesoporous silica nanoparticles as drug carriers for red light-induced drug release.
Chai S; Guo Y; Zhang Z; Chai Z; Ma Y; Qi L
Nanotechnology; 2017 Apr; 28(14):145101. PubMed ID: 28281469
[TBL] [Abstract][Full Text] [Related]
11. Targeting Cancer Cells with Photoactive Silica Nanoparticles.
Borzęcka W; Trindade T; Torres T; Tomé J
Curr Pharm Des; 2016; 22(39):6021-6038. PubMed ID: 27306094
[TBL] [Abstract][Full Text] [Related]
12. Optimized Rhodamine B labeled mesoporous silica nanoparticles as fluorescent scaffolds for the immobilization of photosensitizers: a theranostic platform for optical imaging and photodynamic therapy.
Martins Estevão B; Miletto I; Marchese L; Gianotti E
Phys Chem Chem Phys; 2016 Apr; 18(13):9042-52. PubMed ID: 26967375
[TBL] [Abstract][Full Text] [Related]
13. Defining the therapeutic window of vertebral photodynamic therapy in a murine pre-clinical model of breast cancer metastasis using the photosensitizer BPD-MA (Verteporfin).
Akens MK; Hardisty MR; Wilson BC; Schwock J; Whyne CM; Burch S; Yee AJ
Breast Cancer Res Treat; 2010 Jan; 119(2):325-33. PubMed ID: 19263216
[TBL] [Abstract][Full Text] [Related]
14. X-ray radiation-induced and targeted photodynamic therapy with folic acid-conjugated biodegradable nanoconstructs.
Clement S; Chen W; Deng W; Goldys EM
Int J Nanomedicine; 2018; 13():3553-3570. PubMed ID: 29950835
[TBL] [Abstract][Full Text] [Related]
15. The role of strong hypoxia in tumors after treatment in the outcome of bacteriochlorin-based photodynamic therapy.
Krzykawska-Serda M; Dąbrowski JM; Arnaut LG; Szczygieł M; Urbańska K; Stochel G; Elas M
Free Radic Biol Med; 2014 Aug; 73():239-51. PubMed ID: 24835769
[TBL] [Abstract][Full Text] [Related]
16. Small mesoporous silica nanoparticles as carriers for enhanced photodynamic therapy.
Zhu J; Wang H; Liao L; Zhao L; Zhou L; Yu M; Wang Y; Liu B; Yu C
Chem Asian J; 2011 Sep; 6(9):2332-8. PubMed ID: 21744503
[TBL] [Abstract][Full Text] [Related]
17. Combination of Molecule-Targeted Therapy and Photodynamic Therapy Using Nanoformulated Verteporfin for Effective Uveal Melanoma Treatment.
Song M; Zhu L; Zhang L; Ge X; Cao J; Teng Y; Tian R
Mol Pharm; 2024 May; 21(5):2340-2350. PubMed ID: 38546166
[TBL] [Abstract][Full Text] [Related]
18. BODIPY-doped silica nanoparticles with reduced dye leakage and enhanced singlet oxygen generation.
Wang Z; Hong X; Zong S; Tang C; Cui Y; Zheng Q
Sci Rep; 2015 Jul; 5():12602. PubMed ID: 26211417
[TBL] [Abstract][Full Text] [Related]
19. Magnetic field enhanced cell uptake efficiency of magnetic silica mesoporous nanoparticles.
Liu Q; Zhang J; Xia W; Gu H
Nanoscale; 2012 Jun; 4(11):3415-21. PubMed ID: 22543531
[TBL] [Abstract][Full Text] [Related]
20. Lipid coated mesoporous silica nanoparticles as photosensitive drug carriers.
Yang Y; Song W; Wang A; Zhu P; Fei J; Li J
Phys Chem Chem Phys; 2010 May; 12(17):4418-22. PubMed ID: 20407714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
